Skip to Content


In the US, Betaxolol (betaxolol systemic) is a member of the drug class cardioselective beta blockers and is used to treat Angina Pectoris Prophylaxis and High Blood Pressure.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antihypertensive agent

β-adrenoceptor antagonist (beta blocker), cardioselective

Treatment of coronary heart disease

Glaucoma treatment

Chemical Name

1-[p-[2-(cyclopropylmetoxy)etyl]phenoxy]-3-(isopropylamino)-2-propanol (WHO)

Foreign Names

  • Betaxololum (Latin)
  • Betaxolol (German)
  • Bétaxolol (French)
  • Betaxolol (Spanish)

Generic Names

  • Betaxolol (OS: BAN)
  • Bétaxolol (OS: DCF)
  • Betaxololo (OS: DCIT)
  • SL 75212 (IS)
  • UNII-O0ZR1R6RZ2 (IS)
  • Betaxolol Hydrochloride (OS: BANM, USAN, JAN)
  • ALO 1401-02 (IS)
  • SL 75212-10 (IS)
  • UNII-6X97D2XT0O (IS)
  • Bétaxolol (chlorhydrate de) (PH: Ph. Eur. 8)
  • Betaxolol Hydrochloride (PH: BP 2016, JP XVI, USP 38)
  • Betaxolol hydrochloride (PH: Ph. Eur. 8)
  • Betaxololhydrochlorid (PH: Ph. Eur. 8)
  • Betaxololi hydrochloridum (PH: Ph. Eur. 8)

Brand Names

  • Apixol 0.5%
    Api, Egypt
  • Betac
    Medochemie, Cyprus
  • Betax
    Rompharm, Romania
  • Betaxol
    Aristopharma, Bangladesh
  • Betaxolol Andromaco
    Laboratorios Andromaco, Chile
  • Betaxolol Borg
    Borg, Egypt
  • Betaxolol L.CH.
    Laboratorio Chile, Chile
  • Betaxolol Winthrop
    Winthrop, Tunisia
  • Betopric
    Alcon Farmaceutika, Croatia (Hrvatska)
  • Betoptic
    Alcon, Lebanon; Alcon, Peru; Alcon, Tunisia; Alcon, Turkey
  • Betoptic 0.5%
    Alcon, Egypt; Alcon-Couvreur, Poland
  • Betoptic S
    Alcon, Peru; Alcon, Turkey; Alcon-Couvreur, Poland; Euro Registratie, Netherlands; Alcon, Lithuania
  • Betoptic-S
    A Potamitis Medicare, Cyprus
  • Eifel
    Biogen, Turkey
  • Glucovis
    Beximco, Bangladesh
  • Iobet
    FDC, India
  • Kerlone
    Sanofi Aventis, Tunisia; Sanofi-Synthelabo, Lebanon
  • Ketaxol
    ADWYA, Tunisia
  • Keval
    Pharmaghreb, Tunisia
  • Optibetol
    Warsaw Pharmaceutical Works, Georgia
  • Rialol
    Riyadh Pharma, Oman
  • Along
    Teva Seiyaku, Japan
  • Beof
    Nicolich, Chile
  • Bertocil
    Edol, Portugal
  • Betac
    Medochemie, Lithuania; Medochemie, Latvia; Medochemie, Philippines; Medochemie, Romania; Medochemie, Slovakia; Medochemie, Taiwan; Medochemie Singapore, Singapore
  • Betakyl 0.5%
    Sawai Seiyaku, Japan
  • Betalmic
    Unimed, Czech Republic
  • Betalmic 0.5%
    Unimed Pharma, Slovakia
  • Betamed
    Medochemie, Czech Republic
  • Betarun
    Synmosa, Taiwan
  • Betasel
    Alcon, Argentina
  • Betaxa
    Nycomed, Czech Republic
  • Betaxen
    Barrett Hodgson, Pakistan
  • Betaxol
    Oftalmi, Venezuela
  • Betaxolol 0.5%
    FDC International, United Kingdom
  • Betaxolol Biogaran
    Biogaran, France
  • Betaxolol EG
    EG Labo, France
  • Betaxolol Hydrochloride KVK-TECH
    KVK-TECH, United States
  • Betaxolol Hydrochloride Teva
    Teva Seiyaku, Japan
  • Betaxolol Medochemie
    Medochemie, Poland
  • Betaxolol Mylan
    Mylan, France
  • Betaxolol PMCS
    Pro.Med., Poland
  • Betaxolol Sandoz
    Sandoz, France
  • Betaxolol Teva Sante
    Teva Santé, France
  • Betaxon 0.5%
    Nippon Tenganyaku Kenkyujo, Japan
  • Betoftan
    Rompharm, Russian Federation
  • Betoptic
    Alcon, Australia; Alcon, Brazil; Alcon, Canada; Alcon, Czech Republic; Alcon, Denmark; Alcon, Finland; Alcon, Greece; Alcon, Hungary; Alcon, Ireland; Alcon, Italy; Alcon, South Korea; Alcon, Lithuania; Alcon, Latvia; Alcon, Malaysia; Alcon, Netherlands; Alcon, Norway; Alcon, Oman; Alcon, Philippines; Alcon, Pakistan; Alcon, Portugal; Alcon, Romania; Alcon, Singapore; Alcon, Taiwan; Alcon, South Africa; Alcon Cusi, Spain; Alcon Laboratories UK, United Kingdom; Alcon Nordic, Sweden; Alcon-Couvreur, Belgium; Alcon-Couvreur, Malta; Alconlab, Ecuador; Laboratorios Alcon Chile, Chile
  • Betoptic 0.25%
    Alcon, France
  • Betoptic 0.5%
    Alcon, France; Alcon, New Zealand; Alcon Japan, Japan
  • Betoptic S
    Alcon, Australia; Alcon, Bosnia & Herzegowina; Alcon, Bulgaria; Alcon, Brazil; Alcon, China; Alcon, Czech Republic; Alcon, Estonia; Alcon, Finland; Alcon, Hong Kong; Alcon, Netherlands; Alcon, Norway; Alcon, Romania; Alcon, Serbia; Alcon, Singapore; Alcon, United States; Alcon Couvreur, Georgia; Alcon Nordic, Sweden; Alcon Ophthalmika, Austria; Alconlab, Ecuador; Fisher Farma, Netherlands; Laboratorios Alcon Chile, Chile; SA Alcon Couvreur, Macedonia; Alcon, Switzerland; Alcon, Philippines; Alcon, Venezuela
  • Betoptic S 0.25%
    Alcon, New Zealand
  • Betoptic S 0.5%
    Alcon Japan, Japan
  • Betoptic-S
    Alcon, Greece; Alcon, Malaysia; Alcon Couvreur, Israel
  • Betoptima
    Alcon, Germany; Alcon, Indonesia
  • Bexolo
    Taiwan Biotech, Taiwan
  • Cloridrato de Betaxolol
    Alcon, Brazil; Cristalia, Brazil
  • Kefnan
    Towa Yakuhin, Japan
  • Kerlon
    Sanofi Oy, Finland; Sanofi-Aventis, Italy; Sanofi-Aventis, Netherlands
  • Kerlone
    Lavipharm, Greece; Sanofi Aventis, China; Sanofi-Aventis, Germany; Sanofi-Aventis, France; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Philippines; Sanofi-Aventis, Taiwan; Sanofi-Synthelabo, United States
  • Kerlone mite
    Sanofi-Aventis, Germany
  • Kerlong
    Sanofi, Japan
  • Lokren
    Sanofi-aventis, Czech Republic; Sanofi-Aventis Group, Russian Federation
  • Optibet
    Jayson, Bangladesh; Sanbe, Indonesia
  • Optibetol 0.5%
    Polfa Warszawa, Poland
  • Presmin
    Latinofarma, Brazil
  • Sandoz Betaxolol
    Sandoz, Canada
  • Tarlong
    Taisho Yakuhin, Japan


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.